BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38537982)

  • 21. Prospective Evaluation of Quality of Life and Functional Outcomes after Carbon Ion Radiotherapy for Inoperable Bone and Soft Tissue Sarcomas.
    Komatsu S; Okamoto M; Shiba S; Kaminuma T; Okazaki S; Kiyohara H; Yanagawa T; Nakano T; Ohno T
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.
    Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D
    World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of carbon ion radiotherapy for primary spinal sarcoma.
    Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
    Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential histological findings and clinical response after carbon ion radiotherapy for unresectable sarcoma.
    Hayashi K; Yamamoto N; Shirai T; Takeuchi A; Kimura H; Miwa S; Higuchi T; Abe K; Taniguchi Y; Aiba H; Kiyohara H; Imai R; Ikeda H; Tsuchiya H
    Clin Transl Radiat Oncol; 2017 Feb; 2():41-45. PubMed ID: 29657999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS).
    Cassidy RJ; Indelicato DJ; Gibbs CP; Scarborough MT; Morris CG; Zlotecki RA
    Am J Clin Oncol; 2016 Dec; 39(6):600-603. PubMed ID: 25036470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation process of Toronto Exremity Salvage Score in Italian: A quality of life measure for patients with extremity bone and soft tissue tumors.
    Rossi L; Boffano M; Comandone A; Ferro A; Grignani G; Linari A; Pellegrino P; Piana R; Ratto N; Davis AM
    J Surg Oncol; 2020 Mar; 121(4):630-637. PubMed ID: 31957034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors.
    Takakusagi Y; Saitoh JI; Kiyohara H; Oike T; Noda SE; Ohno T; Nakano T
    Radiat Oncol; 2017 Nov; 12(1):185. PubMed ID: 29166945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
    Kohama I; Yanagawa T; Okamoto M; Ohno T; Chikuda H
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):434-440. PubMed ID: 34811886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
    Zhang H; Yoshikawa K; Tamura K; Tomemori T; Sagou K; Tian M; Kandatsu S; Kamada T; Tsuji H; Suhara T; Suzuki K; Tanada S; Tsujii H
    Clin Cancer Res; 2004 Mar; 10(5):1764-72. PubMed ID: 15014030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical indications for carbon-ion radiotherapy in the UK: A critical review.
    Light E; Bridge P
    Radiography (Lond); 2024 Mar; 30(2):425-430. PubMed ID: 38199158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
    Musha A; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Osu N; Yumisaki H; Adachi A; Takayasu Y; Shino M; Nikkuni O; Ida S; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T
    Anticancer Res; 2022 Mar; 42(3):1439-1446. PubMed ID: 35220237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors.
    Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
    Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local surgery feasibility and safety after carbon ion radiotherapy for primary bone sarcomas.
    Sabe H; Outani H; Imura Y; Takami H; Nakai T; Takenaka S; Kakunaga S; Tamiya H; Wakamatsu T; Nakai S; Demizu Y; Imai R; Okada S
    J Orthop Sci; 2024 May; 29(3):903-907. PubMed ID: 37045686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic spacer placement for recurrent sacral chordoma before carbon ion radiotherapy: A case report.
    Nagai S; Nagayoshi K; Mizuuchi Y; Fujita H; Ohuchida K; Ohtsuka T; Imai R; Nakamura M
    Asian J Endosc Surg; 2020 Oct; 13(4):582-585. PubMed ID: 32097984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Analysis of 20 Cases of Radiation-Associated Sarcoma, Including 4 Cases Treated by Carbon Ion Radiotherapy.
    Negishi T; Matsunobu A; Endo M; Yokoyama R; Kusano S; Furubayashi N; Taguchi K; Shioyama Y; Iida K; Fujiwara T; Setsu N; Matsumoto Y; Nakashima Y; Kohashi K; Yamamoto H; Oda Y; Nakamura M
    Oncology; 2022; 100(3):148-154. PubMed ID: 34915507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Tomizawa K; Shibuya K; Shiba S; Okazaki S; Miyasaka Y; Oishi M; Okamoto M; Ohno T
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1100-1109. PubMed ID: 36870514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
    Ahern V; Adeberg S; Fossati P; Garrett R; Hoppe B; Mahajan A; Orlandi E; Orecchia R; Prokopovich D; Seuntjens J; Thwaites D; Trifiletti D; Tsang R; Tsuji H
    Radiother Oncol; 2023 Oct; 187():109816. PubMed ID: 37480996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.